Chatterjee M - Search Results

1

Pasotuxizumab, a BiTE^® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.

Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: chatterjee m. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Free article. Clinical Trial.

2

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells.

Hönemann D, Chatterjee M, Savino R, Bommert K, Burger R, Gramatzki M, Dörken B, Bargou RC. Hönemann D, et al. Among authors: chatterjee m. Int J Cancer. 2001 Sep 1;93(5):674-80. doi: 10.1002/ijc.1388. Int J Cancer. 2001. PMID: 11477577 Free article.

3

A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells.

Hönemann D, Kufer P, Rimpler MM, Chatterjee M, Friedl S, Riecher F, Bommert K, Dörken B, Bargou RC. Hönemann D, et al. Among authors: chatterjee m. Leukemia. 2004 Mar;18(3):636-44. doi: 10.1038/sj.leu.2403264. Leukemia. 2004. PMID: 14737072

4

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.

Chatterjee M, Stühmer T, Herrmann P, Bommert K, Dörken B, Bargou RC. Chatterjee M, et al. Blood. 2004 Dec 1;104(12):3712-21. doi: 10.1182/blood-2004-04-1670. Epub 2004 Aug 5. Blood. 2004. PMID: 15297310 Free article.

5

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.

Stühmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, Gerecke C, Theurich S, Cigliano L, Manz RA, Daniel PT, Bommert K, Vassilev LT, Bargou RC. Stühmer T, et al. Among authors: chatterjee m. Blood. 2005 Nov 15;106(10):3609-17. doi: 10.1182/blood-2005-04-1489. Epub 2005 Aug 4. Blood. 2005. PMID: 16081689 Free article.

6

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma.

Zöllinger A, Stühmer T, Chatterjee M, Gattenlöhner S, Haralambieva E, Müller-Hermelink HK, Andrulis M, Greiner A, Wesemeier C, Rath JC, Einsele H, Bargou RC. Zöllinger A, et al. Among authors: chatterjee m. Blood. 2008 Oct 15;112(8):3403-11. doi: 10.1182/blood-2007-11-119362. Epub 2008 Jul 17. Blood. 2008. PMID: 18635812 Free article.

7

Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease.

Stuehler C, Mielke S, Chatterjee M, Duell J, Lurati S, Rueckert F, Einsele H, Bargou RC, Topp MS. Stuehler C, et al. Among authors: chatterjee m. Blood. 2009 Sep 24;114(13):2829-36. doi: 10.1182/blood-2009-06-224600. Epub 2009 Aug 5. Blood. 2009. PMID: 19657113 Free article.

8

Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival.

Steinbrunn T, Stühmer T, Gattenlöhner S, Rosenwald A, Mottok A, Unzicker C, Einsele H, Chatterjee M, Bargou RC. Steinbrunn T, et al. Among authors: chatterjee m. Blood. 2011 Feb 10;117(6):1998-2004. doi: 10.1182/blood-2010-05-284422. Epub 2010 Dec 13. Blood. 2011. PMID: 21149634 Free article.

9

Preclinical activity of the novel orally bioavailable HSP90 inhibitor NVP-HSP990 against multiple myeloma cells.

Stühmer T, Iskandarov K, Gao Z, Bumm T, Grella E, Jensen MR, Einsele H, Chatterjee M, Bargou RC. Stühmer T, et al. Among authors: chatterjee m. Anticancer Res. 2012 Feb;32(2):453-62. Anticancer Res. 2012. PMID: 22287732

10

Combined targeting of MEK/MAPK and PI3K/Akt signalling in multiple myeloma.

Steinbrunn T, Stühmer T, Sayehli C, Chatterjee M, Einsele H, Bargou RC. Steinbrunn T, et al. Among authors: chatterjee m. Br J Haematol. 2012 Nov;159(4):430-40. doi: 10.1111/bjh.12039. Epub 2012 Sep 17. Br J Haematol. 2012. PMID: 22985491 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,276 results

Search Page